Emanuele Puca
Otelfingen, ZH, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Dynamics, Pharmacokinetics, and Dosimetry of First-in-Human [68Ga]Ga-OncoACP3-DOTA PET in Patients with Prostate Cancer.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: December 19, 2025
Targeted TNF Potentiates the Activity of Bispecific T-cell Engagers in Solid Tumors by Turning Cold Tumors Hot.
Journal: Cancer immunology research
Published: December 09, 2025
Imaging-guided optimization of biodistribution and antitumor efficacy of L19-based immunocytokines.
Journal: Translational oncology
Published: November 17, 2025
Quantitative Mass Spectrometry-Based Biodistribution of Monoclonal Antibodies: An Alternative to Radio-Biodistribution.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 22, 2025
Tumor-targeted IL2 promotes specific CD8+ T cells private clonal expansion enhancing lymphoma control.
Journal: Journal of experimental & clinical cancer research : CR
Published: October 20, 2025
Translational and First-in-Human Positron Emission Tomography Targeting Prostatic Acid Phosphatase in Prostate Cancer Using the Ligand [68Ga]Ga-OncoACP3-DOTA.
Journal: European urology
Published: September 11, 2025
Generation and characterization of novel high-affinity fully human antibodies targeting prostate-specific membrane antigen and prostatic acid phosphatase.
Journal: Antibody therapeutics
Published: July 18, 2025
A comparative analysis of tumor markers reveals EDA fibronectin as a promising target in high-grade serous ovarian cancer.
Journal: Journal of ovarian research
Published: May 07, 2025
Combinatorial treatment with upadacitinib abrogates systemic toxicity of a tumor-targeted IL-2 fusion protein.
Journal: Journal for immunotherapy of cancer
Published: April 08, 2025
Immunocompetent mouse models of cancer reveal the superiority of cellular targets over stromal targets for the development of anticancer bispecific antibodies.
Journal: Molecular cancer therapeutics
Published: March 28, 2025
Phenylalanine-Based DNA-Encoded Chemical Libraries for the Discovery of Potent and Selective Small Organic Ligands Against Markers of Cancer and Immune Cells.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 24, 2025
Past, present and future of drug conjugates for cancer therapy.
Journal: Nature cancer
Published: October 17, 2024
Last Updated: 09/26/2026